Clinical Trial Update: Deferasirox, Cholecalciferol, and Azacitidine in the Treatment of Newly Diagnosed AML Patients Over 65 [Phase 2]

View source ↗

Summary

Phase 2 trial investigating deferasirox, cholecalciferol, and azacitidine in newly diagnosed acute myeloid leukemia patients over 65; study terminated with resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• AZACITIDINE (AZACITIDINE)
• Cholecalciferol (Vitamin D3)
• Deferasirox (Deferasirox)

Snippet

Sponsor: Elizabeth Henry | Conditions: Acute Myeloid Leukemia | Phase 2 | Status: TERMINATED | Results posted: 2020-02-27